Heart Pump's impact on failing hearts to be measured in new study
NCT ID NCT07534462
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study will observe how the Impella 5.5 heart pump changes the way the heart squeezes and works in adults with end-stage heart failure. Researchers will use ultrasound (echocardiography) to measure heart function before, right after, and 7-14 days after the pump is placed. The goal is to better understand the pump's effects, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentler tug on the Heart's reins spark recovery?
- Heart pump vs. pills: which keeps End-Stage heart failure patients alive longer?
- Could a simple pump flow measure predict organ health in heart device patients?
- New study aims to simplify heart monitoring for pump patients
- Heart pump could outperform drugs in advanced heart failure
- Heart pump study tracks Long-Term survival in failing hearts